Merck Rallies Of Drug Trial Results


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Merck & Co., Inc. (NYSE: MRK) shares are trading higher by $1.09 at $57.03 in Thursday's session. The catalyst for the rally is the announcement that Keytruda has met primary and secondary endpoints.


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

After a higher open, it retreated and found support just above Wednesday's close ($56.09) at $56.13 and began to move higher. So far, it has reached $57.31 and isn't far off that level.

That marks the highest level for the issue since early May, when it put in a pair of highs at the $57.80 area.

Posted In: TechnicalsIntraday UpdateMoversTrading Ideas